Picture EBD Group World of Partnering Opportunities 650x100px

Organisation › Details

Omrix Biopharmaceuticals Ltd. (IL)

https://www.omrix.com

	Group	Johnson & Johnson (JnJ) (Group)
	Industry	BIOTECH

	Region	Tel Aviv
	Country	Israel
	Street	MDA Blood Center, Tel Hashomer Hospital
	City	52621 Tel Aviv
	Tel	+972-3-531-6531
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Johnson & Johnson (JnJ) (Group)

[1] Asgard Therapeutics AB. (3/14/24). "Press Release: Asgard Therapeutics Announces €30 Million Series A Financing to Advance Its First-in-Class in vivo Cell Reprogramming Platform for Immuno-oncology". Lund....
[2] Sanofi S.A.. (10/3/23). "Press Release: Sanofi Announces Agreement for Potential First-in-Class Vaccine against Extraintestinal Pathogenic E. coli". Paris....
[3] Nanobiotix S.A.. (7/10/23). "Press Release: Nanobiotix Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3". Paris & Cambridge, MA....
[4] Alia Therapeutics S.r.l.. (5/5/23). "Press Release: Alia Therapeutics Names Letizia Goretti as Chief Executive Officer". Milan....
[5] Evotec SE. (1/26/23). "Press Release: Evotec Announces Agreement with Janssen to Develop Immune-based Therapies". Hamburg....
[6] Evotec SE. (6/14/22). "Press Release: Evotec Enters a Drug Discovery Collaboration with Janssen". Hamburg....
[7] Nouscom AG. (5/17/22). "Press Release: Nouscom Announces Janssen Receives US FDA IND Clearance for VAC85135, an ‘Off-The-Shelf’ Cancer Immunotherapy Developed using Nouscom’s Proprietary Viral Vector Platform". Basel....
[8] GlycoEra AG. (5/3/22). "Press Release: GlycoEra AG Appoints Ganesh V. Kaundinya as President and Chief Executive Officer". Schlieren & Boston, MA....
[9] VectivBio Holding AG. (4/21/22). "Press Release: VectivBio Appoints Patrick Malloy as Senior Vice President, Investor Relations & Strategic Communications". Basel....
[10] Aqemia SAS. (2/14/22). "Press Release: Aqemia Announces Pilot Study with Janssen to Utilize Aqemia’s Physics-driven Drug Discovery Technology". Antwerp & Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]